To make cancer and other life-changing health conditions easier to live with by treating and managing them from home.
Location: United Kingdom, England, London
Phone: +44 20 3020 0030
Total raised: $61.28M
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | Startup Cr... | startupcre... |
| 14.01.2021 | Plug and P... | plugandpla... |
| - | Parkwalk A... | parkwalkad... |
| 03.08.2023 | BGF Ventur... | bgf.co.uk |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 18.08.2023 | Series A | $20M | - |
| 02.08.2023 | Series A | $20.54M | - |
| 01.08.2023 | Series A | $20.74M | - |
Mentions in press and media 13
| Date | Title | Description |
| 18.08.2023 | Entia – raises $20m in Series A funding round | Parkwalk is thrilled to announce our latest investment into Entia as part of a $20m series A funding round to launch the world’s most comprehensive monitoring solution for patients undergoing cancer therapy. |
| 02.08.2023 | Entia Raises $12M in Funding | Entia, a London, UK-based medical technology company, raised $12m in funding. The round was led by BGF, with participation from existing seed investors including Parkwalk and Sussex Place Ventures. The company intends to use the funds to la... |
| 01.08.2023 | Entia raises £16 million to fund launch of world’s most comprehensive cancer therapy monitoring solution | Healthtech company Entia has closed a successful £16 million Series A financing round. The round was led by BGF and Parkwalk, plus other existing investors, with the capital earmarked for the UK commercial rollout and US regulatory approval... |
| 01.08.2023 | United Kingdom-based Entia Bags raises EUR 18.7 million in Series A financing | London, United Kingdom-based healthtech company monitoring cancer Entia Bags closed its Series A financing at EUR 18.7 million. The company announced the closure on July 29, 2023. BGF, as well as Parkwalk, led the financing for the firm. Me... |
| 27.07.2023 | UK-based Entia raises €18.6M to improve the lives of people undergoing cancer treatment | Read this article in: London-based Entia, a healthtech company that claims to transform cancer care to improve the everyday lives of patients undergoing cancer treatment, announced on Wednesday, July 26, that it has secured £16M (nearly €18... |
| 27.07.2023 | Remote patient monitoring for cancer treatment: Entia raises £16M in Series A funding | Offering at-home blood testing to individuals undergoing cancer treatment, London’s Entia has raised £16 million in a Series A funding round. The investment will provide the needed capital to rollout the company’s remote patient monitoring ... |
| 12.10.2021 | Pfizer-backed London medtech Entia to launch virtual oncology solution in UK by 2022, raises $12M funding | Over 50 percent of systemic anti-cancer therapies cause haematological toxicity. The management of this condition accounts for 8 percent of all cancer treatment costs and leads to frequent and disruptive healthcare visits for patients. To m... |
| 11.10.2021 | Medtech startup Entia picks up $12M | London-based Entia has raised $12 million in a round led by BGF and Parkwalk. The funds will be used to launch its home blood monitoring device for cancer patients. The startup has secured over $25 million in total funding. View details |
| - | Entia | “Entia is transforming the delivery of cancer care in a way that suits the needs of patients and eases healthcare systems by offering virtual oncology solutions.” |
| - | Entia raises £9 million to launch virtual oncology solution | Entia, a medical technology business, which recently announced a commercial partnership with Pfizer UK, raised £9 million earlier in the year in a funding round co-led by UK growth capital investor, BGF and growth fund manager, Parkwalk, ... |
Show more